Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.
India Infoline News Service / 08:59, Sep 15, 2014
Many a times parents overlook other goals as they are too busy focusing on just one goal, that is on their child's education. They are too emotionally involved in achieving this particular goal that they forget planning for their retirement and saving for other emergencies.